Nonclinical pharmacokinetics and in vitro metabolism of H3B-6545, a novel selective ERα covalent antagonist (SERCA).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2019, v. 83, n. 1, p. 151, doi. 10.1007/s00280-018-3716-3
- By:
- Publication type:
- Article